期刊文献+
共找到4篇文章
< 1 >
每页显示 20 50 100
片仔癀茵胆平肝胶囊的解酒保肝机理
1
《医药世界》 2001年第11期63-63,共1页
漳州片仔癀药业股份有限公司荣誉产品——片仔癀茵胆平肝胶囊茵陈、龙胆草、黄芩、猪胆膏、栀子、当归、白芍等中药组成。据现代研究证实中药茵陈、龙胆草、栀子均有一定保肝利胆作用。能减轻四氯化碳引起的肝损害,保护肝细胞、并能促... 漳州片仔癀药业股份有限公司荣誉产品——片仔癀茵胆平肝胶囊茵陈、龙胆草、黄芩、猪胆膏、栀子、当归、白芍等中药组成。据现代研究证实中药茵陈、龙胆草、栀子均有一定保肝利胆作用。能减轻四氯化碳引起的肝损害,保护肝细胞、并能促进胆汁分泌、排泄、胆囊括约肌的收缩而起到利胆。 展开更多
关键词 片仔癀茵胆平胶囊 解酒机理 保肝机理 中药 治疗
下载PDF
茵陈化学成分和药理作用研究进展 被引量:81
2
作者 谢韬 梁敬钰 刘净 《海峡药学》 2004年第1期8-13,共6页
本文对中药茵陈的化学成分和药理作用进行了综述。
关键词 滨蒿 茵陈蒿 化学成分 药理作用 中药 活性 保肝机理
下载PDF
基于药物代谢酶途径的何首乌“时-毒-效”变化规律研究 被引量:1
3
作者 李炯侠 郭延丽 +5 位作者 刘巧 高峰 董泰玮 陈琳 李瑞 卫培峰 《四川中医》 2021年第11期48-53,共6页
目的:观察何首乌不同炮制时间对正常小鼠和肝损伤小鼠肝脏的损伤作用及肝脏药物代谢酶mRNA表达的影响,初步探讨其肝损伤发生机理。方法:分别给正常小鼠和肝损伤小鼠以何首乌不同炮制品,观察其对肝脏的损伤及保护作用;不同炮制方法炮制... 目的:观察何首乌不同炮制时间对正常小鼠和肝损伤小鼠肝脏的损伤作用及肝脏药物代谢酶mRNA表达的影响,初步探讨其肝损伤发生机理。方法:分别给正常小鼠和肝损伤小鼠以何首乌不同炮制品,观察其对肝脏的损伤及保护作用;不同炮制方法炮制的何首乌灌胃小鼠后对血液生化指标的影响采用微板法检测;分析小鼠肝脏的病理变化则采用HE染色法;用RT-PCR方法检测何首乌不同炮制品对大鼠肝脏药物代谢酶CYP2E1、CYP3A、CYP1A2mRNA相对表达量的的影响。结果:灌胃何首乌不同炮制品4周后的正常小鼠,肝脏均出现了不同程度的损伤,其中生首乌与清蒸8h组小鼠肝损伤显著,然而灌胃何首乌炮制时间越长的小鼠肝损伤程度小;各给药组的CYP2E1、CYP3A、CYP1A2mRNA酶的表达量较空白组均显著下降,且延长炮制时间各表达量呈逐渐下降趋势。而给肝损伤小鼠灌胃给药后,阳性药组的小鼠肝损伤出现明显好转,各何首乌给药组无明显好转,但是,灌胃何首乌炮制时间越长的肝损伤小鼠,均出现了好转的趋势。结论:何首乌对正常小鼠可引起不同程度的肝脏损伤,且随炮制时间延长,肝损伤程度有所降低,调节机体药物代谢酶CYP2E1、CYP3A、CYP1A2mRNA表达量可能是其毒性机理;而对肝损伤小鼠虽有好转的趋势,但没有显著性差异。 展开更多
关键词 何首乌 炮制时间 损伤 保肝机理
下载PDF
Management of liver cirrhosis between primary care and specialists 被引量:5
4
作者 Ignazio Grattagliano Enzo Ubaldi +1 位作者 Leonilde Bonfrate Piero Portincasa 《World Journal of Gastroenterology》 SCIE CAS CSCD 2011年第18期2273-2282,共10页
This article discusses a practical, evidence-based approach to the diagnosis and management of liver cirrhosis by focusing on etiology, severity, presence of complications, and potential home-managed treatments. Relev... This article discusses a practical, evidence-based approach to the diagnosis and management of liver cirrhosis by focusing on etiology, severity, presence of complications, and potential home-managed treatments. Relevant literature from 1985 to 2010 (PubMed) was reviewed. The search criteria were peer-reviewed full papers published in English using the following MESH headings alone or in combination: "ascites", "liver fibrosis", "cirrhosis", "chronic hepatitis", "chronic liver disease", "decompensated cirrhosis", "hepatic encephalopathy", "hypertransaminasemia", "liver transplantation" and "portal hypertension". Forty-nine papers were selected based on the highest quality of evidence for each section and type (original, randomized controlled trial, guideline, and review article), with respect to specialist setting (Gastroenterology, Hepatology, and Internal Medicine) and primary care. Liver cirrhosis from any cause represents an emerging health issue due to the increasing prevalence of the disease and its complications worldwide. Primary care physicians play a key role in early identification of risk factors, in the management of patients for improving quality and length of life, and for preventing complications. Specialists, by contrast, should guide specific treatments, especially in the case of complications and for selecting patient candidates for liver transplantation. An integrated approach between specialists and primary care physicians is essential for providing better outcomes and appropriate home care for patients with liver cirrhosis. 展开更多
关键词 ASCITES Family medicine Hepatic encephalopathy HYPERTRANSAMINASEMIA Portal hypertension
下载PDF
上一页 1 下一页 到第
使用帮助 返回顶部